Advanced Search

On 24 January 2018, PMI presented on our Modified Risk Tobacco Product Application for IQOS before the Tobacco Products Scientific Advisory Committee (TPSAC). The presentation covers the IQOS system and heating technology, an outline of our scientific assessment results, perception and behavior data, plans to introduce IQOS in the U.S., and population health impact modeling.

 

You can view the full slide deck here and read the full script here.

Related Articles

Tobacco regulations and smoke free products

FDA Modified Risk Tobacco Product Application
Scientific Update Issue 04

PMI Presents to US FDA Advisory Committee; Important Milestone in the Scientific Review of Platform 1
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.